Published in Blood Weekly, August 24th, 2006
According to recently published research from Japan, "D2-40 antibody is raised against an oncofetal antigen, the M2A antigen. It has been used as a marker for lymphatic endothelium as well as mesothelioma and cerebellar hemangioblastoma.
"In the developing cerebellum," said Y. Nakamura and colleagues at St. Mary's Hospital in Fukuoka, "positive D2-40 immunoreactivity was found in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.